DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R Agonists
- Sponsor
- University of Dundee
- Study ID
- NCT01575301
- Status
- Completed
Conditions
- Diabetes
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Exenatide, Liraglutide — DRUGDosage, frequency and duration not specified by protocol
Study Details
The purpose of this study is to collect a cohort of patients treated with GLP-1R Agonists and to assess phenotypic, genetic and genomic biomarkers of glycaemic response to these agents.
Key Dates
- Start date
- Mar 31, 2011
- Status verified
- Apr 2018
- Primary completion
- Jul 31, 2015
- Completion
- Dec 11, 2015
Study Design
- Enrollment
- 411 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- BASIC_SCIENCE
Primary Outcome Measure
Change in HbA1c between baseline and 6 months [ Time Frame: 6 months ]
Related Studies
- Diabetes and Heart Disease Risk in BlacksRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Urinary Vitamin C Loss in Diabetic SubjectsRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Personalized Environment and Genes StudyRecruiting · National Institute of Environmental Health Sciences (NIEHS) · Chapel Hill, North Carolina
- Genetics of Obesity, Diabetes, and Heart Disease in African Diaspora PopulationsEnrolling By Invitation · National Human Genome Research Institute (NHGRI) · Bethesda, Maryland